Skip to content

Multimedia informed consent trial

Evaluation of an alternative informed consent procedure for clinical trials conducted in The Gambia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201402000775274
Enrollment
300
Registered
2014-02-21
Start date
2013-06-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Informed consent comprehension

Interventions

Written (paper) informed consent Group

Sponsors

Medical Research Council Unit, The Gambia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Participants must be in the planned primaquine trial at Basse and Jahaly trial sites in The Gambia; 2) Participants must be able to speak any of the 3 major Gambian languages: Mandinka, Fula or Wolof

Exclusion criteria

Exclusion criteria: 1) Participants must not have communication or visual problems (e.g. language problems, deafness, blindness); 2) Participants must not have cognitive impairment or intellectual disability

Design outcomes

Primary

MeasureTime frame
Proportion of participants with ¿good recall¿ as measured by proportion of participants who succeed in selecting correct answers to the closed ended and multiple choice question items on the validated comprehension questionnaire at days 7,14 and 28 after intervention visit.

Secondary

MeasureTime frame
Proportion of participants with ¿good recall¿ as measured by proportion of participants who succeed in selecting correct answers to the closed ended and multiple choice question items on the validated comprehension questionnaire at days 7,14 and 28 after intervention visit.;Acceptability and ease of use of multimedia consent tool and audio digitised comprehension questionnaire as measured by participants¿ responses during 1st and 2nd visits in the pilot study;Acceptability and ease of use of multimedia consent tool and audio digitised questionnaire as measured by participants¿ responses in primaquine trial during focus group discussion sessions at days 35 and 42 after intervention visit.

Countries

Gambia

Contacts

Public ContactMuhammed Afolabi

Medical Research Council Unit, The Gambia

mafolabi@mrc.gm+220-7059861

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026